Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Brookside Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 46
Average round size
info
The average size of a deal this fund participated in
$54M
Portfolio companies 31
Rounds per year 1.35
Lead investments 8
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.23
Exits 26
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Genetics
  • Biopharma
Summary

In 1990 was created Brookside Capital, which is appeared as VC. The main office of represented VC is situated in the San Francisco. The fund was located in North America if to be more exact in United States.

The top activity for fund was in 2015. The typical startup value when the investment from Brookside Capital is more than 1 billion dollars. The top amount of exits for fund were in 2014. This Brookside Capital works on 33 percentage points more the average amount of lead investments comparing to the other organizations. The fund is generally included in 2-6 deals every year. The real fund results show that this VC is 2 percentage points more often commits exit comparing to other companies. The common things for fund are deals in the range of 50 - 100 millions dollars.

The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Brookside Capital, startups are often financed by MPM Capital, Wellcome Trust, Sutter Hill Ventures. The meaningful sponsors for the fund in investment in the same round are Sutter Hill Ventures, Skyline Ventures, MPM Capital. In the next rounds fund is usually obtained by Sutter Hill Ventures, Oxford Finance LLC, Meritech Capital Partners.

Besides them, we counted 3 critical employees of this fund in our database.

Among the most popular fund investment industries, there are Biopharma, Therapeutics. Among the most popular portfolio startups of the fund, we may highlight MuleSoft, Spark Therapeutics, DocuSign. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Besides, a startup needs to be aged 6-10 years to get the investment from the fund.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
4DX Australia, Melbourne, Victoria
Action Potential Venture Capital Cambridge, Massachusetts, United States
Arm China -
Highnote Foundry New York, New York, United States
Martin Currie City of Edinburgh, Scotland, United Kingdom
Nautica New York, New York, United States
RSP Architects Minneapolis, Minnesota, United States
Sorbon Investments Beaconsfield, Buckinghamshire, United Kingdom
Space Angels New York, New York, United States
Vault -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Socar

Car Sharing
Communities
Transportation
$56M27 Nov 2015 South Korea, Gyeonggi-do, South Korea

SevOne

Application Performance Management
Computer
Enterprise Software
Software
$47M23 Sep 2015 Boston, Massachusetts, United States

Translate Bio

Biotechnology
Genetics
Medical
Therapeutics
$63M23 Jul 2015 Cambridge, Massachusetts, United States

Qoo10-Indonesia

Consumer
E-Commerce
$82M20 Jul 2015 Surabaya

Voyager Therapeutics

Biotechnology
Genetics
Health Care
Life Science
$60M13 Apr 2015 Cambridge, Massachusetts, United States

REGENXBIO

Biopharma
Biotechnology
Genetics
Therapeutics
$30M21 Jan 2015 Maryland, United States

Spark Therapeutics

Biotechnology
Genetics
Medical
Therapeutics
$72M27 May 2014 Philadelphia, Pennsylvania, United States

Dicerna Pharmaceuticals

Biotechnology
Genetics
Health Care
Pharmaceutical
$60M31 Jul 2013 Massachusetts, United States

Radius Health

Biotechnology
Drug Discovery
Health Care
Health Diagnostics
Pharmaceutical
Pharmaceuticals
Women's
$66M26 Jul 2011 Cambridge, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Brookside Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 46
Average round size 54M
Rounds per year 1.35
Peak activity year 2015
Lead investments 8
Follow on index 0.23
Exits 26

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Socar

Car Sharing
Communities
Transportation
$56M27 Nov 2015 South Korea, Gyeonggi-do, South Korea

SevOne

Application Performance Management
Computer
Enterprise Software
Software
$47M23 Sep 2015 Boston, Massachusetts, United States

Translate Bio

Biotechnology
Genetics
Medical
Therapeutics
$63M23 Jul 2015 Cambridge, Massachusetts, United States

Qoo10-Indonesia

Consumer
E-Commerce
$82M20 Jul 2015 Surabaya

Voyager Therapeutics

Biotechnology
Genetics
Health Care
Life Science
$60M13 Apr 2015 Cambridge, Massachusetts, United States

REGENXBIO

Biopharma
Biotechnology
Genetics
Therapeutics
$30M21 Jan 2015 Maryland, United States

Spark Therapeutics

Biotechnology
Genetics
Medical
Therapeutics
$72M27 May 2014 Philadelphia, Pennsylvania, United States

Dicerna Pharmaceuticals

Biotechnology
Genetics
Health Care
Pharmaceutical
$60M31 Jul 2013 Massachusetts, United States

Radius Health

Biotechnology
Drug Discovery
Health Care
Health Diagnostics
Pharmaceutical
Pharmaceuticals
Women's
$66M26 Jul 2011 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: